Finance

Lists
Why is 600721 down 8,55%?
Dive Deeper
600721:SHA
Xinjiang Bai Hua Cun Pharma Tech Co Ltd
CN¥11,02
-8,55%
(-1,03) 1D
16 Okt., 15:00:02 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600721...
Open
CN¥12,11
High
CN¥12,60
Low
CN¥11,00
Mkt. cap
4,63 mjd
Avg. vol.
109,83 m
Volume
129,49 m
Dividend
0,36%
Quarterly dividend
CN¥0,01
Ex-dividend date
08 Mei 2026
P/E ratio
141,35
52-wk high
CN¥16,68
52-wk low
CN¥6,25
EPS
CN¥0,08
Shares outstanding
400,39 m
No. of employees
690
Open
CN¥12,11
High
CN¥12,60
Low
CN¥11,00
Mkt. cap
4,63 mjd
Avg. vol.
109,83 m
Volume
129,49 m
Dividend
0,36%
Quarterly dividend
CN¥0,01
Ex-dividend date
08 Mei 2026
P/E ratio
141,35
52-wk high
CN¥16,68
52-wk low
CN¥6,25
EPS
CN¥0,08
Shares outstanding
400,39 m
No. of employees
690
News stories
From web sources and news partners
About Xinjiang Bai Hua Cun Pharma Tech Co Ltd
CEO-
Employees690
Founded1959
Headquarters-
SectorPharmaceutical industry
Websitexjbhc.net
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
96,52 m
89,71 m
67,18 m
90,17 m
Cost of goods sold
37,13 m
85,29 m
34,92 m
55,22 m
Cost of revenue
37,13 m
85,29 m
34,92 m
55,22 m
Research and development expenses
5,91 m
6,30 m
4,03 m
5,23 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
19,01 m
14,60 m
15,21 m
16,69 m
Operating expense
25,37 m
16,82 m
22,87 m
29,84 m
Total operating expenses
62,51 m
102,11 m
57,80 m
85,06 m
Operating income
34,01 m
-12,40 m
9,38 m
5,11 m
Other non operating income
96,03 k
-19,62 k
-14,06 k
-72,30 k
EBT including unusual items
8,17 m
5,44 m
7,26 m
9,45 m
EBT excluding unusual items
34,94 m
-14,36 m
10,38 m
5,79 m
Income tax expense
978,65 k
-2,57 m
620,69 k
1,34 m
Effective tax rate
11,98%
-47,26%
8,55%
14,14%
Other operating expenses
1,32 m
1,44 m
1,40 m
1,14 m
Net income
7,19 m
8,01 m
6,64 m
8,12 m
Net profit margin
7,45%
8,93%
9,89%
9,00%
Earnings per share
-
-
-
-
Interest and investment income
834,46 k
-
1,09 m
749,00 k
Interest expense
-
-1,88 m
-79,79 k
-
Net interest expenses
834,46 k
-1,88 m
1,01 m
749,00 k
Depreciation and amortization charges
-
-
-
-
EBITDA
38,42 m
-7,94 m
13,84 m
9,69 m
Gain or loss from assets sale
-
-884,00
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme